Patents by Inventor Francois Lang

Francois Lang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Melanoma antigen peptide and uses thereof
    Patent number: 9475841
    Abstract: The present invention relates to a melanoma antigen peptide comprising the amino acids sequence selected in the group consisting of SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14 or SEQ ID NO: 15 or a function-conservative variant thereof. Moreover the invention also relates to a melanoma antigen peptide according to the invention for use in the prevention or the treatment of melanoma in patient.
    Type: Grant
    Filed: May 22, 2012
    Date of Patent: October 25, 2016
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE D'ANGERS
    Inventors: Nathalie Labarriere, Francois Lang, Mathilde Bobinet, Anne Rogel
  • NOVEL MELANOMA ANTIGEN PEPTIDE AND USES THEREOF
    Publication number: 20150291660
    Abstract: The present invention relates to a melanoma antigen peptide comprising the amino acids sequence selected in the group consisting of SEQ ID NO: 1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4 or SEQ ID NO:5 or a function-conservative variant thereof. Moreover the invention also relates to a melanoma antigen peptide according to the invention for use in the prevention or the treatment of melanoma in patient.
    Type: Application
    Filed: May 22, 2012
    Publication date: October 15, 2015
    Applicants: UNIVERSITE D'ANGERS, INSERM (INSSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE D'ANGERS
    Inventors: Nathalie Labarriere, Francois Lang, Mathilde Bobinet, Anne Rogel
  • NOVEL MELANOMA ANTIGEN PEPTIDE AND USES THEREOF
    Publication number: 20150132329
    Abstract: The present invention relates to a melanoma antigen peptide comprising the amino acids sequence selected in the group consisting of SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14 or SEQ ID NO: 15 or a function-conservative variant thereof. Moreover the invention also relates to a melanoma antigen peptide according to the invention for use in the prevention or the treatment of melanoma in patient.
    Type: Application
    Filed: May 22, 2012
    Publication date: May 14, 2015
    Applicants: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE D'ANGERS
    Inventors: Nathalie Labarriere, Francois Lang, Mathilde Bobinet, Anne Rogel
  • Antibody or fragment thereof recognizing Avitag™ and uses thereof
    Patent number: 8431394
    Abstract: The application relates to antibodies which recognize the AviTag™ peptide of sequence MSGLNDIFEAQKIEWHE (SEQ ID No. 1) and to fragments thereof which recognize SEQ ID No. 1, wherein said antibodies or said fragments thereof recognize polypeptides containing SEQ ID No. 1 at their NH2 terminus and polypeptides containing SEQ ID No. 1 at their COOH terminus. The application further relates to a method for sorting target cells presenting on their surface a surface marker from a mixed cell population comprising the steps of: a) incubating said mixed cell population with a tagged adapter which binds to said surface marker of said target cells, wherein said adapter is bound to an antibody which recognizes said tag, and wherein said antibody is immobilized on a solid support. b) collecting said target cells.
    Type: Grant
    Filed: July 11, 2008
    Date of Patent: April 30, 2013
    Assignee: INSERM (Institut National de la Santé et de la Recherche Médicale)
    Inventors: Francois Lang, Karine Bernardeau, Regis Bouquie, Nathalie Labarriere
  • Means for detection and purification of CD8+ T lymphocyte populations specific to peptides presented in the context of HLA
    Patent number: 8309312
    Abstract: The invention concerns multimers developed from recombinant proteins analogues of MHC class I.
    Type: Grant
    Filed: October 1, 2009
    Date of Patent: November 13, 2012
    Assignee: Institut National de la Sante et de la Recherche
    Inventors: Francois Lang, Marie Bodinier, Francois Davodeau, Marc Bonneville
  • Antibody or Fragment Thereof Recognizing AvitagTM and Uses Thereof
    Publication number: 20100197009
    Abstract: The application relates to antibodies which recognize the AviTag™ peptide of sequence MSGLNDIFEAQKIEWHE (SEQ ID No. 1) and to fragments thereof which recognize SEQ ID No. 1, wherein said antibodies or said fragments thereof recognize polypeptides containing SEQ ID No. 1 at their NH2 terminus and polypeptides containing SEQ ID No. 1 at their COOH terminus. The application further relates to a method for sorting target cells presenting on their surface a surface marker from a mixed cell population comprising the steps of: a) incubating said mixed cell population with a tagged adapter which binds to said surface marker of said target cells, wherein said adapter is bound to an antibody which recognizes said tag, and wherein said antibody is immobilized on a solid support. b) collecting said target cells.
    Type: Application
    Filed: July 11, 2008
    Publication date: August 5, 2010
    Applicant: INSERM(Institut National de la Sante et de la Recherche Medicale)
    Inventors: Francois Lang, Karine Bernardeau, Regis Bouquie, Nathalie Labarriere
  • Means for detection and purification of CD8+ T lymphocyte populations specific to peptides presented in the context of HLA
    Publication number: 20040209314
    Abstract: The invention concerns multimers developed from recombinant proteins analogues of MHC class I.
    Type: Application
    Filed: January 28, 2004
    Publication date: October 21, 2004
    Applicant: Institut National De La Sante Et De La Recherche Medicale France
    Inventors: Francois Lang, Marie Bodinier, Francois Davodeau, Marc Bonneville